Advertisement
Screener

CYTOSORBENTS CORPORATION (CTSO) Stock-Based Compensation

2.8 / 5 stars · 68/120 Roast Me

CYTOSORBENTS CORPORATION Stock-Based Compensation

CYTOSORBENTS CORPORATION (CTSO) reported Stock-Based Compensation of $368.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:ShareBasedCompensation · last filed 2026-08-06

  • CYTOSORBENTS CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $368.00K, a 35.55% decline year-over-year.
  • CYTOSORBENTS CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $544.00K, a 33.50% decline year-over-year.
  • CYTOSORBENTS CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $886.00K, a 3.70% decline year-over-year.
  • CYTOSORBENTS CORPORATION share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $488.00K, a 45.23% decline year-over-year.
  • CYTOSORBENTS CORPORATION share-based payment arrangement, noncash expense for fiscal 2025 was $2.77M, a 26.46% decline from fiscal 2024.
  • CYTOSORBENTS CORPORATION share-based payment arrangement, noncash expense for fiscal 2024 was $3.76M, a 9.51% decline from fiscal 2023.
  • CYTOSORBENTS CORPORATION share-based payment arrangement, noncash expense for fiscal 2023 was $4.16M, a 21.38% increase from fiscal 2022.
  • CYTOSORBENTS CORPORATION share-based payment arrangement, noncash expense for fiscal 2022 was $3.42M, a 14.86% decline from fiscal 2021.
Period endShare-based Payment Arrangement, Noncash Expense 3 monthShare-based Payment Arrangement, Noncash Expense 3 month as first filedShare-based Payment Arrangement, Noncash Expense 6 monthShare-based Payment Arrangement, Noncash Expense 6 month as first filedShare-based Payment Arrangement, Noncash Expense 9 monthShare-based Payment Arrangement, Noncash Expense 9 month as first filedShare-based Payment Arrangement, Noncash Expense 12 monthShare-based Payment Arrangement, Noncash Expense 12 month as first filed
2026-06-30$368.00K
10-Q · filed 2026-08-06
$912.00K
10-Q · filed 2026-08-06
$1.80M
derived: sum of 3 quarters · filed 2026-08-06
$2.29M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$544.00K
10-Q · filed 2026-05-13
$1.43M
derived: sum of 2 quarters · filed 2026-05-13
$1.92M
derived: sum of 3 quarters · filed 2026-05-13
$2.49M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$886.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
$1.37M
derived: sum of 2 quarters · filed 2026-03-30
$1.95M
derived: sum of 3 quarters · filed 2026-08-06
$2.77M
10-K · filed 2026-03-30
2025-09-30$488.00K
10-Q · filed 2025-11-13
$1.06M
derived: sum of 2 quarters · filed 2026-08-06
$1.88M
10-Q · filed 2025-11-13
$2.80M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30$571.00K
10-Q · filed 2026-08-06
$1.39M
10-Q · filed 2026-08-06
$2.31M
derived: sum of 3 quarters · filed 2026-08-06
$3.20M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31$818.00K
10-Q · filed 2026-05-13
$818.43K
10-Q · filed 2025-05-14
$1.74M
derived: sum of 2 quarters · filed 2026-05-13
$2.63M
derived: sum of 3 quarters · filed 2026-05-13
$3.62M
derived: sum of 4 quarters · filed 2026-05-13
2024-12-31$920.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30
$1.81M
derived: sum of 2 quarters · filed 2026-03-30
$2.80M
derived: sum of 3 quarters · filed 2026-03-30
$3.76M
10-K · filed 2026-03-30
$3.76M
10-K · filed 2025-03-31
2024-09-30$891.00K
10-Q · filed 2025-11-13
$1.88M
derived: sum of 2 quarters · filed 2025-11-13
$2.84M
10-Q · filed 2025-11-13
$2.34M
10-Q · filed 2024-11-07
$4.51M
derived: sum of 4 quarters · filed 2025-11-13
2024-06-30$989.00K
10-Q · filed 2025-08-07
$1.95M
10-Q · filed 2025-08-07
$1.56M
10-Q · filed 2024-08-13
$3.62M
derived: sum of 3 quarters · filed 2025-08-07
$4.70M
derived: sum of 4 quarters · filed 2025-08-07
2024-03-31$959.47K
10-Q · filed 2025-05-14
$734.21K
10-Q · filed 2024-05-09
$2.63M
derived: sum of 2 quarters · filed 2025-05-14
$3.71M
derived: sum of 3 quarters · filed 2025-05-14
$4.28M
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$1.67M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31
$2.75M
derived: sum of 2 quarters · filed 2025-03-31
$3.33M
derived: sum of 3 quarters · filed 2025-03-31
$4.16M
10-K · filed 2025-03-31
$3.33M
10-K · filed 2024-03-15
2023-09-30$1.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07
$1.66M
derived: sum of 2 quarters · filed 2024-11-07
$2.49M
10-Q · filed 2024-11-07
$3.36M
derived: sum of 4 quarters · filed 2024-11-07
2023-06-30$570.24K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
$1.40M
10-Q · filed 2024-08-13
$2.27M
derived: sum of 3 quarters · filed 2024-08-13
$3.28M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$830.28K
10-Q · filed 2024-05-09
$1.70M
derived: sum of 2 quarters · filed 2024-05-09
$2.71M
derived: sum of 3 quarters · filed 2024-05-09
$3.47M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$869.42K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15
$1.87M
derived: sum of 2 quarters · filed 2024-03-15
$2.64M
derived: sum of 3 quarters · filed 2024-03-15
$3.42M
10-K · filed 2024-03-15
2022-09-30$1.01M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
$1.77M
derived: sum of 2 quarters · filed 2023-11-09
$2.55M
10-Q · filed 2023-11-09
$3.35M
derived: sum of 4 quarters · filed 2024-03-15
2022-06-30$761.27K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01
$1.55M
10-Q · filed 2023-08-01
$2.35M
derived: sum of 3 quarters · filed 2024-03-15
$3.34M
derived: sum of 4 quarters · filed 2024-03-15
2022-03-31$787.42K
10-Q · filed 2023-05-02
$1.58M
derived: sum of 2 quarters · filed 2024-03-15
$2.58M
derived: sum of 3 quarters · filed 2024-03-15
$4.14M
derived: sum of 4 quarters · filed 2024-03-15
2021-12-31$796.56K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15
$1.80M
derived: sum of 2 quarters · filed 2024-03-15
$3.35M
derived: sum of 3 quarters · filed 2024-03-15
$4.02M
10-K · filed 2024-03-15
2021-09-30$998.64K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$2.56M
derived: sum of 2 quarters · filed 2022-11-03
$3.22M
10-Q · filed 2022-11-03
$3.87M
derived: sum of 4 quarters · filed 2023-03-09
2021-06-30$1.56M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02
$2.23M
10-Q · filed 2022-08-02
$2.88M
derived: sum of 3 quarters · filed 2023-03-09
$3.96M
derived: sum of 4 quarters · filed 2023-03-09
2021-03-31$667.19K
10-Q · filed 2022-05-03
$1.32M
derived: sum of 2 quarters · filed 2023-03-09
$2.41M
derived: sum of 3 quarters · filed 2023-03-09
$3.45M
derived: sum of 4 quarters · filed 2023-03-09
2020-12-31$649.87K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
$1.74M
derived: sum of 2 quarters · filed 2023-03-09
$2.78M
derived: sum of 3 quarters · filed 2023-03-09
$3.51M
10-K · filed 2023-03-09
2020-09-30$1.09M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04
$2.13M
derived: sum of 2 quarters · filed 2021-11-04
$2.86M
10-Q · filed 2021-11-04
$3.36M
derived: sum of 4 quarters · filed 2022-03-10
2020-06-30$1.05M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03
$1.78M
10-Q · filed 2021-08-03
$2.27M
derived: sum of 3 quarters · filed 2022-03-10
$3.07M
derived: sum of 4 quarters · filed 2022-03-10
2020-03-31$729.43K
10-Q · filed 2021-05-04
$1.22M
derived: sum of 2 quarters · filed 2022-03-10
$2.02M
derived: sum of 3 quarters · filed 2022-03-10
$2.17M
derived: sum of 4 quarters · filed 2022-03-10
2019-12-31$491.27K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10
$1.29M
derived: sum of 2 quarters · filed 2022-03-10
$1.44M
derived: sum of 3 quarters · filed 2022-03-10
$1.67M
10-K · filed 2022-03-10
2019-09-30$802.33K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04
$947.10K
derived: sum of 2 quarters · filed 2020-11-04
$1.17M
10-Q · filed 2020-11-04
$2.75M
derived: sum of 4 quarters · filed 2021-03-09
2019-06-30$144.76K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04
$372.42K
10-Q · filed 2020-08-04
$1.95M
derived: sum of 3 quarters · filed 2021-03-09
$2.22M
derived: sum of 4 quarters · filed 2021-03-09
2019-03-31$227.66K
10-Q · filed 2020-05-05
$1.80M
derived: sum of 2 quarters · filed 2021-03-09
$2.07M
derived: sum of 3 quarters · filed 2021-03-09
$4.14M
derived: sum of 4 quarters · filed 2021-03-09
2018-12-31$1.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09
$1.85M
derived: sum of 2 quarters · filed 2021-03-09
$3.91M
derived: sum of 3 quarters · filed 2021-03-09
$4.44M
10-K · filed 2021-03-09
2018-09-30$273.77K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05
$2.34M
derived: sum of 2 quarters · filed 2019-11-05
$2.86M
10-Q · filed 2019-11-05
$4.33M
derived: sum of 4 quarters · filed 2020-03-05
2018-06-30$2.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06
$2.59M
10-Q · filed 2019-08-06
$4.05M
derived: sum of 3 quarters · filed 2020-03-05
$5.01M
derived: sum of 4 quarters · filed 2020-03-05
2018-03-31$524.45K
10-Q · filed 2019-05-07
$1.99M
derived: sum of 2 quarters · filed 2020-03-05
$2.95M
derived: sum of 3 quarters · filed 2020-03-05
$3.75M
derived: sum of 4 quarters · filed 2020-03-05
2017-12-31$1.46M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-05
$2.42M
derived: sum of 2 quarters · filed 2020-03-05
$3.22M
derived: sum of 3 quarters · filed 2020-03-05
$3.31M
10-K · filed 2020-03-05
2017-09-30$960.03K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$1.76M
derived: sum of 2 quarters · filed 2018-11-06
$1.85M
10-Q · filed 2018-11-06
$3.88M
derived: sum of 4 quarters · filed 2019-03-07
2017-06-30$798.71K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02
$890.99K
10-Q · filed 2018-08-02
$2.92M
derived: sum of 3 quarters · filed 2019-03-07
$3.05M
derived: sum of 4 quarters · filed 2019-03-07
2017-03-31$92.28K
10-Q · filed 2018-05-08
$2.13M
derived: sum of 2 quarters · filed 2019-03-07
$2.25M
derived: sum of 3 quarters · filed 2019-03-07
$2.74M
derived: sum of 4 quarters · filed 2019-03-07
2016-12-31$2.03M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07
$2.16M
derived: sum of 2 quarters · filed 2019-03-07
$2.65M
derived: sum of 3 quarters · filed 2019-03-07
$2.76M
10-K · filed 2019-03-07
2016-09-30$124.26K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09
$616.94K
derived: sum of 2 quarters · filed 2017-11-09
$724.02K
10-Q · filed 2017-11-09
$846.08K
derived: sum of 4 quarters · filed 2018-03-08
2016-06-30$492.69K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07
$599.77K
10-Q · filed 2017-08-07
$721.82K
derived: sum of 3 quarters · filed 2018-03-08
$835.62K
derived: sum of 4 quarters · filed 2018-03-08
2016-03-31$107.08K
10-Q · filed 2017-05-08
$229.13K
derived: sum of 2 quarters · filed 2018-03-08
$342.94K
derived: sum of 3 quarters · filed 2018-03-08
$425.79K
derived: sum of 4 quarters · filed 2018-03-08
2015-12-31$122.05K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08
$235.86K
derived: sum of 2 quarters · filed 2018-03-08
$318.70K
derived: sum of 3 quarters · filed 2018-03-08
$382.28K
10-K · filed 2018-03-08
2015-09-30$113.80K
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07
$196.65K
derived: sum of 2 quarters · filed 2016-11-07
$260.23K
10-Q · filed 2016-11-07
$805.80K
derived: sum of 4 quarters · filed 2017-03-03
2015-06-30$82.85K
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09
$146.43K
10-Q · filed 2016-08-09
$692.00K
derived: sum of 3 quarters · filed 2017-03-03
$737.41K
derived: sum of 4 quarters · filed 2017-03-03
2015-03-31$63.58K
10-Q · filed 2016-05-09
$609.15K
derived: sum of 2 quarters · filed 2017-03-03
$654.56K
derived: sum of 3 quarters · filed 2017-03-03
$702.05K
derived: sum of 4 quarters · filed 2017-03-03
2014-12-31$545.57K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03
$590.98K
derived: sum of 2 quarters · filed 2017-03-03
$638.47K
derived: sum of 3 quarters · filed 2017-03-03
$695.84K
10-K · filed 2017-03-03
2014-09-30$45.41K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13
$92.90K
derived: sum of 2 quarters · filed 2015-11-13
$150.27K
10-Q · filed 2015-11-13
2014-06-30$47.49K
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13
$104.86K
10-Q · filed 2015-08-13
2014-03-31$57.37K
10-Q · filed 2015-05-11
2013-12-31$456.94K
10-K · filed 2015-03-31

Similar stocks

Stock NameCountryMarket CapPE Ratio
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
Mobia Medical, Inc. (MOBI)United States$0.293B
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
PRO DEX INC (PDEX)United States$0.234B13.64
Embecta Corp. (EMBC)United States$0.319B2.10
Neuronetics, Inc. (STIM)United States$0.216B-3.25